MIRA INFORM REPORT

 

 

Report Date :

29.06.2012

 

IDENTIFICATION DETAILS

 

Name :

HEALTHCARE TECH CORPORATION

 

 

Registered Office :

Tazawa Soko 4F, 5-17-8 Yotsuya Fuchu Tokyo-Metrop 183-0035

 

 

Country :

Japan

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

February  1991

 

 

Legal Form :

Limited Company (Kabushiki Kaisha)

 

 

Line of Business :

Import, wholesale of medical instruments, apparatus, generic pharmacies,

 

 

No. of Employees :

93

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

--

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Company name and address

 

HEALTHCARE TECH CORPORATION

REGD NAME:    Healthcare Tech KK

MAIN OFFICE:  Tazawa Soko 4F, 5-17-8 Yotsuya Fuchu Tokyo-Metrop 183-0035 JAPAN

Tel: 042-354-8280      Fax: 042-354-8288

 

URL:                 http://www.healthcare-tech.co.jp

E-Mail address: (thru the URL)

 

 

ACTIVITIES

 

Import, wholesale of medical instruments, apparatus, generic pharmacies,

 

BRANCHES

 

Tokyo, Osaka, Nagoya

 

 

OFFICERS

 

KEN’ICHI WATANABE, PRES    Tetsuya Yoshino, dir

Kojiro Imaoka, dir                       Yusuke Shiraishi, dir

                       

Yen Amount:     In million Yen, unless otherwise stated

 

 

SUMMARY

 

FINANCES        FAIR                             A/SALES          Yen 21,000 M

PAYMENTS      NO COMPLAINTS          CAPITAL           Yen 40 M

TREND UP                                WORTH            Yen 200 M

STARTED         1991                             EMPLOYES      93

 

 

COMMENT

 

TRADING FIRM SPECIALIZING IN MEDICAL INSTUMENTS, OWNED BY

ITOCHU CORP.

FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS.

                       

                       

 

HIGHLIGHTS

           

            The subject company was established on the basis of a medical division separated from Itochu Corp (See REGISTRATION).  This is a trading firm for import and wholesale of medical instruments, apparatus, medical supplies, generic pharmaceuticals, other.  Clients include major hospitals, university attached hospitals, other, nationwide.

 

 

FINANCIAL INFORMATION

           

            The sales volume for Mar/2011 fiscal term amounted to Yen 21,000 million, a 17% up from Yen 17,900 million in the previous term.  The Great North Japan Earthquake created additional & acute demand for medical equipment & supplies.  Import increased.  The net profit was posted at Yen 50 million, compared with Yen 51 million a year ago.

 

            For the term that ended Mar 2012 the net profit was projected at Yen 60 million, on a 7% rise in turnover, to Yen 22,500 million.   Final results are yet to be released. 

 

The financial situation is considered FAIR and good for ORDINARY business engagements. 

 

 

REGISTRATION

 

Date Registered:  Feb 1991

Legal Status:      Limited Company (Kabushiki Kaisha)

Authorized:         3,200 shares

Issued:                800 shares

Sum:                   Yen 40 million

Major shareholders (%): Itochu Corp* (100)

 

*.. One of big 5 general trading firms, Tokyo, founded 1949, listed Tokyo S/E, capital Yen

202,241 million, sales Yen 11,978,276 million, operating profit Yen 272,620 million, recurring profit Yen 41,174 million, net profit Yen 300,505 million, total assets Yen 6,507,273 million, net worth Yen 1,696,141 million, employees 73,211, pres Masahiro Kuji

Consolidated Financials are attached (See SUPPLEMENTS)

 

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

           

Activities: Imports and wholesales medical instruments, equipment, medical supplies, pharmaceuticals, other (--100%)

 

Clients: [Hospitals, medical institutions, wholesalers] Tokyo Women’s Medical College Hospital, Nippon University attached Hikarigaoka Hospital, Tokyu Corporations, Kawaguchi City Medical Institutions, other 

No. of accounts: 500

Domestic areas of activities: Nationwide

Suppliers: [Mfrs, wholesalers] Mediceo Corp, Innomedics Medical Institutions, Technowood Corp, Suzuken Co, Nipro Corp, Kawasumi Laboratories, Toho Pharmaceutical, other

 

Payment record: No Complaints

 

Location: Business area in Fuchu, Tokyo-Metrop.  Office premises at the caption address are leased and maintained satisfactorily.

 

Bank References:

Mizuho Bank (Gaienmae)

Relations: Satisfactory

 

 

FINANCES

(In Million Yen)

 

       Terms Ending:

31/03/2012

31/03/2011

31/03/2010

31/03/2009

Annual Sales

 

22,500

21,000

17,900

17,500

Recur. Profit

 

 

 

 

 

Net Profit

 

60

50

51

71

Total Assets

 

 

5,545

5,586

4,940

Current Assets

 

 

5,391

5,492

4,859

Current Liabs

 

 

5,301

5,357

4,726

Net Worth

 

 

200

195

184

Capital, Paid-Up

 

 

40

40

40

Div.P.Share(Ą)

 

 

0.00

0.00

0.00

<Analytical Data>

(%)

(%)

(%)

(%)

    S.Growth Rate

7.14

17.32

2.29

6.06

    Current Ratio

 

..

101.70

102.52

102.81

    N.Worth Ratio

..

3.61

3.49

3.72

    R.Profit/Sales

 

..

..

..

..

    N.Profit/Sales

0.27

0.24

0.28

0.41

    Return On Equity

..

25.00

26.15

38.59

 Forecast (or estimated) figures for the 31/03/2012 fiscal term.

 

 

SUPPLEMENTS

 

CONSOLIDATED FINANCIALS O THE PARENT, ITOCHU CORP

FINANCES: (Consolidated in million yen)

 

 

 

Terms Ending:

31/03/2012

31/03/2011

INCOME STATEMENT

 

 

 

  Annual Sales

 

11,978,276

11,393,584

 

  Cost of Sales

8,947,829

10,417,206

 

      GROSS PROFIT

3,030,447

976,378

 

  Selling & Adm Costs

2,757,822

720,075

 

      OPERATING PROFIT

272,620

256,303

 

  Non-Operating P/L

68,554

-73,971

 

      RECURRING PROFIT

341,174

182,332

 

      NET PROFIT

300,505

161,114

BALANCE SHEET

 

 

 

 

  Cash

 

513,489

633,756

 

  Receivables

 

1,653,412

1,426,677

 

  Inventory

 

574,345

504,342

 

  Securities, Marketable

2,770

3,560

 

  Other Current Assets

636,070

507,321

 

      TOTAL CURRENT ASSETS

3,380,086

3,075,656

 

  Property & Equipment

707,933

643,974

 

  Intangibles

 

 

 

 

  Investments, Other Fixed Assets

2,419,254

1,957,079

 

      TOTAL ASSETS

6,507,273

5,676,709

 

  Payables

 

1,434,241

1,236,561

 

  Short-Term Bank Loans

415,268

241,915

 

 

 

 

 

 

  Other Current Liabs

601,565

565,066

 

      TOTAL CURRENT LIABS

2,451,074

2,043,542

 

  Debentures

 

 

 

 

  Long-Term Bank Loans

2,259,717

2,160,772

 

  Reserve for Retirement Allw

64,304

52,564

 

  Other Debts

 

36,037

20,877

 

      TOTAL LIABILITIES

4,811,132

4,277,755

 

      MINORITY INTERESTS

 

 

 

Common stock

202,241

202,241

 

Additional paid-in capital

112,370

112,370

 

Retained earnings

1,296,265

1,036,095

 

Evaluation p/l on investments/securities

(244,394)

(193,683)

 

Others

 

332,344

244,605

 

Treasury stock, at cost

(2,685)

(2,674)

 

      TOTAL S/HOLDERS` EQUITY

1,696,141

1,398,954

 

      TOTAL EQUITIES

6,507,273

5,676,709

CONSOLIDATED CASH FLOWS

 

 

 

 

Terms ending:

31/03/2012

31/03/2011

 

Cash Flows from Operating Activities

 

212,830

335,361

 

Cash Flows from Investment Activities

-416,315

-230,866

 

Cash Flows from Financing Activities

84,704

53,202

 

Cash, Bank Deposits at the Term End

 

513,489

633,756

ANALYTICAL RATIOS            Terms ending:

31/03/2012

31/03/2011

 

 

Net Worth (S/Holders' Equity)

1,696,141

1,398,954

 

 

Current Ratio (%)

137.90

150.51

 

 

Net Worth Ratio (%)

26.07

24.64

 

 

Recurring Profit Ratio (%)

2.85

1.60

 

 

Net Profit Ratio (%)

2.51

1.41

 

 

Return On Equity (%)

17.72

11.52

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.56.92

UK Pound

1

Rs.88.91

Euro

1

Rs.71.25

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.